Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development

Ernest A. Adeghate, Huba Kalász, Saeeda Al Jaberi, Jennifer Adeghate, Kornelia Tekes

Research output: Contribution to journalEditorialpeer-review

10 Citations (Scopus)
Original languageEnglish
Pages (from-to)85-93
Number of pages9
JournalExpert Opinion on Investigational Drugs
Issue number2
Publication statusPublished - 2021


  • T2DM comorbidities
  • Type 2 Diabetes mellitus
  • cardiovascular diseases
  • hypoglycemic agents
  • renal diseases, pharmacotherapy

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this